Thursday, July 9, 2026

Drug profile · INN

betazole hydrochloride

betazole hydrochloride (HISTALOG) is a histamine h2 receptor agonist. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — betazole hydrochloride
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

betazole hydrochloride (HISTALOG) is a histamine h2 receptor agonist. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN betazole hydrochloride
Brand HISTALOG
Mechanism Histamine H2 receptor agonist
Target Histamine H2 receptor
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Histamine H2 receptor agonist

Primary target: Histamine H2 receptor

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. cimetidine Histamine H2 receptor antagonist
  2. cimetidine hydrochloride Histamine H2 receptor antagonist
  3. famotidine Histamine H2 receptor antagonist
  4. nizatidine Histamine H2 receptor antagonist
  5. ranitidine hydrochloride Histamine H2 receptor antagonist
  6. methantheline bromide Histamine H2 receptor antagonist

Frequently asked questions

What is betazole hydrochloride?

betazole hydrochloride (HISTALOG) is a histamine h2 receptor agonist. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for betazole hydrochloride?

HISTALOG is a marketed brand name for betazole hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of betazole hydrochloride?

betazole hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.